Skip to content
Clinical Trials – home
Institut Gustave Roussy
Sponsor

Institut Gustave Roussy

France 114 Rue Edouard Vaillant, 94800 Villejuif, France

About the sponsor

Research activity includes non-small cell lung cancer, small-cell lung cancer, and other poorly differentiated neuroendocrine carcinomas, with additional interest in pancreatic ductal adenocarcinoma, oligometastatic disease, and biomarker-defined tumour subsets.

  • NSCLC
  • SCLC and neuroendocrine carcinomas
  • Pancreatic cancer
  • Oligometastatic solid tumours

Work in this area also extends to metastatic renal cell carcinoma and KRAS G12C-mutated lung cancer, reflecting a strong focus on targeted and immunologic treatment strategies.

About Specializations

Institut Gustave Roussy runs clinical trials in conditions such as Non-small cell lung cancer, Neoplasm, Breast cancer, Rectal adenocarcinoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

40 clinical trials

Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cabozantinib
  • Sponsor:Institut Gustave Roussy
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:HYDROGEN PEROXIDE
  • Sponsor:Institut Gustave Roussy
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Valemetostat Tosilate
  • Sponsor:Institut Gustave Roussy
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:ASP3082
  • Sponsor:Institut Gustave Roussy
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Azacitidine
  • Sponsor:Institut Gustave Roussy
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Leuprorelin Acetate
  • Sponsor:Institut Gustave Roussy
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Tarlatamab
  • Sponsor:Institut Gustave Roussy
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Institut Gustave Roussy
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Cabozantinib
  • Sponsor:Institut Gustave Roussy
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Institut Gustave Roussy
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years
  • Substances:Busulfan
  • Sponsor:Institut Gustave Roussy
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Tretinoin
  • Sponsor:Institut Gustave Roussy

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.